Merck Tbk (MERK) - Total Assets

Latest as of September 2025: Rp987.93 Billion IDR ≈ $57.89 Million USD

Based on the latest financial reports, Merck Tbk (MERK) holds total assets worth Rp987.93 Billion IDR (≈ $57.89 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Merck Tbk book value and equity for net asset value and shareholders' equity analysis.

Merck Tbk - Total Assets Trend (2000–2024)

This chart illustrates how Merck Tbk's total assets have evolved over time, based on quarterly financial data.

Merck Tbk - Asset Composition Analysis

Current Asset Composition (December 2024)

Merck Tbk's total assets of Rp987.93 Billion consist of 74.2% current assets and 25.9% non-current assets.

Asset Category	Amount (IDR)	% of Total Assets
Cash & Equivalents	Rp0.00	9.2%
Accounts Receivable	Rp180.19 Billion	18.8%
Inventory	Rp391.92 Billion	41.0%
Property, Plant & Equipment	Rp211.90 Billion	22.1%
Intangible Assets	Rp1.89 Billion	0.2%
Goodwill	Rp0.00	0.0%

Asset Composition Trend (2000–2024)

This chart illustrates how Merck Tbk's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MERK market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Merck Tbk's current assets represent 74.2% of total assets in 2024, an increase from 0.0% in 2000.
Cash Position: Cash and equivalents constituted 9.2% of total assets in 2024, down from 19.9% in 2000.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
Asset Diversification: The largest asset category is inventory at 41.0% of total assets.

Merck Tbk Competitors by Total Assets

Key competitors of Merck Tbk based on total assets are shown below.

Company	Country	Total Assets
Daihan Pharmaceutical Co.Ltd KQ:023910	Korea	₩344.02 Billion
Aurobindo Pharma Limited NSE:AUROPHARMA	India	Rs525.46 Billion
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	China	CN¥56.56 Billion
Ningbo Menovo Pharm Co Ltd SHG:603538	China	CN¥4.75 Billion
Zhejiang Xianju Pharmaceutical Co Ltd SHE:002332	China	CN¥7.26 Billion
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	China	CN¥2.26 Billion
Zhejiang Cheng Yi Pharmaceutical Co Ltd SHG:603811	China	CN¥1.69 Billion
Hainan Honz Pharmaceutical Co SHE:300086	China	CN¥1.88 Billion

Merck Tbk - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	6.76	4.53	2.55
Quick Ratio	3.79	1.70	1.36
Cash Ratio	0.00	0.00	0.00
Working Capital	Rp647.46 Billion	Rp522.16 Billion	Rp412.06 Billion

Merck Tbk - Advanced Valuation Insights

This section examines the relationship between Merck Tbk's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.63
Latest Market Cap to Assets Ratio	0.00
Asset Growth Rate (YoY)	-0.1%
Total Assets	Rp956.94 Billion
Market Capitalization	$110.25 Million USD

Valuation Analysis

Below Book Valuation: The market values Merck Tbk's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Merck Tbk's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Merck Tbk (2000–2024)

The table below shows the annual total assets of Merck Tbk from 2000 to 2024.

Year	Total Assets	Change
2024-12-31	Rp956.94 Billion ≈ $56.07 Million	-0.09%
2023-12-31	Rp957.81 Billion ≈ $56.12 Million	-7.69%
2022-12-31	Rp1.04 Trillion ≈ $60.80 Million	+1.11%
2021-12-31	Rp1.03 Trillion ≈ $60.14 Million	+10.36%
2020-12-31	Rp929.90 Billion ≈ $54.49 Million	+3.20%
2019-12-31	Rp901.06 Billion ≈ $52.80 Million	-28.66%
2018-12-31	Rp1.26 Trillion ≈ $74.01 Million	+49.13%
2017-12-31	Rp847.01 Billion ≈ $49.63 Million	+13.85%
2016-12-31	Rp743.93 Billion ≈ $43.59 Million	+15.94%
2015-12-31	Rp641.65 Billion ≈ $37.60 Million	-10.46%
2014-12-31	Rp716.60 Billion ≈ $41.99 Million	+2.82%
2013-12-31	Rp696.95 Billion ≈ $40.84 Million	+22.39%
2012-12-31	Rp569.43 Billion ≈ $33.37 Million	-2.56%
2011-12-31	Rp584.39 Billion ≈ $34.24 Million	+34.41%
2010-12-31	Rp434.77 Billion ≈ $25.48 Million	+0.18%
2009-12-31	Rp433.97 Billion ≈ $25.43 Million	+15.71%
2008-12-31	Rp375.06 Billion ≈ $21.98 Million	+13.29%
2007-12-31	Rp331.06 Billion ≈ $19.40 Million	+17.11%
2006-12-31	Rp282.70 Billion ≈ $16.57 Million	+29.66%
2005-12-31	Rp218.03 Billion ≈ $12.78 Million	+8.76%
2004-12-31	Rp200.47 Billion ≈ $11.75 Million	+0.07%
2003-12-31	Rp200.33 Billion ≈ $11.74 Million	+16.24%
2002-12-31	Rp172.34 Billion ≈ $10.10 Million	+5.91%
2001-12-31	Rp162.72 Billion ≈ $9.53 Million	+25.47%
2000-12-31	Rp129.68 Billion ≈ $7.60 Million	--

About Merck Tbk

JK:MERK Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$110.25 Million

Rp1.88 Trillion IDR

Market Cap Rank

#18800 Global

#329 in Indonesia

Share Price

Rp4200.00

Change (1 day)

-2.33%

52-Week Range

Rp2790.00 - Rp4300.00

All Time High

Rp4843.89